Home » Biotechnology » Next Generation Sequencing Market

Next Generation Sequencing Market By Technology (Sequencing by Synthesis, Sequencing by Ligation, Ion Semiconductor Sequencing, Nanopore Sequencing, Others), By Applications (Bioinformatics, Diagnostics, Agriculture and Animal Research, Drug Discovery, Genetic Research, Others (Clinical Bacteriology, Oncology, Etc.)), By End User (Research Institutes, Pharmaceuticals, Biotechnology Companies, Hospitals, Academic Institutes ), By Diagnostics (Cancer, Neonatal Screening, Infectious Disease, Reproductive Health, Genetic Testing), By Region – Growth, Future Prospects And Competitive Analysis 2020- 2030

Summary
Table Of Content

Market Overview

The Next Generation Sequencing (NGS) market currently holds a significant valuation of USD 5,809.8 million (2022). It is anticipated that by 2030, the market will surge to an astounding USD 21,485.69 million, reflecting an impressive CAGR of 20.54% from 2023 through 2030. This robust growth signifies the rapid adoption of NGS technologies across various sectors, including genomics, diagnostics, and personalized medicine.

The market encompasses the development, manufacturing, and distribution of state-of-the-art NGS technologies, such as high-throughput sequencing platforms, reagents, and related services. These technologies find extensive utility in research institutions, clinical settings, and commercial entities. The market is propelled by an unwavering pursuit of precision, accuracy, and expediency in genomic sequencing, facilitating significant advancements in diagnostic capabilities, genetic research, and personalized medicine. As the NGS market continues its impressive growth trajectory, it becomes an increasingly indispensable component of the broader life sciences and healthcare sectors, underscoring the prominent shift towards data-driven and personalized approaches in these fields.

Market Growth Drivers and Trends

The expansion of the Next Generation Sequencing (NGS) market is being propelled by several key trends and growth drivers. One significant trend is the emergence of genomic medicine, which integrates genomics into medical practice and increases the demand for NGS technologies. As healthcare shifts towards more personalized and precise approaches, the importance of thorough and accurate genetic information becomes paramount. NGS enables comprehensive genomic profiling, empowering clinicians to deliver personalized and effective treatment plans.

Technological advancements in NGS platforms also contribute to the adoption of these technologies. Constant innovations in sequencing speed, accuracy, and cost-effectiveness drive this trend. Additionally, improved data analysis tools and software enhance the interpretation of complex genomic data, enabling more efficient analysis.

Furthermore, increasing research and development activities in genomics play a critical role in driving the growth of the NGS market. Public and private entities are investing more in genomic research, leading to a higher demand for high-throughput sequencing platforms and other NGS solutions.

The growing awareness and prevalence of genetic disorders worldwide further fuel the growth of the NGS market. The need for early and accurate diagnosis of genetic disorders creates a demand for NGS technologies.

Overall, these trends and growth drivers are propelling the expansion of the Next Generation Sequencing (NGS) market, driving innovation, and improving healthcare outcomes.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market restraint factors

Despite the positive growth trajectory, certain market restraints have the potential to impede the progress of the Next Generation Sequencing (NGS) market. A primary constraint is the high cost associated with NGS technologies. The substantial investments required for initial equipment acquisition, along with ongoing maintenance and necessary reagents, can pose a significant barrier for many institutions, particularly those in developing regions. This challenge is further magnified when considering that the cost of NGS is influenced by various variables such as the size of the genome being sequenced, the level of coverage required, the sequencing technology utilized, and the bioinformatics analysis needed to process and interpret the data. Even with subsidies, the price of NGS, especially for whole-genome sequencing (WGS) or large-scale initiatives, remains considerably high.

Another major hindrance is the scarcity of skilled personnel. The operation and data interpretation of NGS technologies demand highly trained professionals. Unfortunately, there is a shortage of such professionals who possess the requisite expertise to effectively handle and interpret the vast amount of complex genomic data generated by NGS.

Data storage and management issues also present significant constraints. The sheer volume of data generated by NGS necessitates robust and secure data storage and management systems. Many organizations may encounter challenges related to data storage, data security, and privacy concerns.

Challenges and opportunities

The increasing adoption of personalized medicine and the growing utilization of genomic data in diagnostics and therapeutics present lucrative opportunities for market participants. Moreover, the rising demand for genetic testing in direct-to-consumer genomics, prenatal testing, and oncology indicates a promising expansion of the market. Bridging the gap between genomic data and clinical application holds significant potential to revolutionize healthcare delivery.

Another area of potential lies in the developing markets of Asia, Africa, and Latin America, which currently lack extensive infrastructure for genomic research and diagnostics but are making investments in healthcare sector development.

Despite these opportunities, certain challenges exist. Data security and privacy remain major concerns, given the need to store and analyze vast genomic datasets. The ethical implications of genome sequencing also pose a challenge, requiring the industry to address issues of consent, disclosure, and potential misuse of genetic information. Additionally, the industry faces the challenge of requiring specialized, highly skilled labor to operate next-generation sequencing (NGS) technologies and interpret their findings. Investing in training is crucial to building the necessary workforce capacity. Lastly, the high costs associated with NGS technologies may limit their accessibility, particularly in low and middle-income countries.

The future of the NGS market will depend on the industry’s ability to effectively capitalize on these opportunities and overcome the challenges. It will require a combination of technological innovation, strategic partnerships, effective regulatory frameworks, and intelligent investment. The next few years promise to be a dynamic and transformative period in the field of next-generation sequencing.

Regulatory Analysis

In the realm of Next Generation Sequencing (NGS), regulatory compliance plays a critical role that directly impacts market dynamics. Various global and regional regulatory bodies oversee the implementation and use of NGS technologies, with the primary ones being the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the China National Medical Products Administration (NMPA), among others. These organizations establish guidelines for NGS-based product development, clinical testing, and diagnostic applications, exerting significant influence on market operations.

The FDA has been actively establishing a regulatory pathway for NGS-based tests, striking a balance between ensuring patient safety and fostering innovation. The administration has released guidelines for the design, development, and validation of NGS-based in vitro diagnostics (IVDs) used for hereditary diseases as well as infectious disease diagnostics.

Similarly, the EMA regulates NGS technologies through its guidelines under the In Vitro Diagnostic Medical Devices Regulation (IVDR). The IVDR proposes more stringent post-market surveillance and places increased emphasis on clinical evidence, directly shaping NGS market trends in Europe.

In the rapidly expanding Chinese market, the NMPA has also implemented regulations for genetic testing products, including NGS technologies. The regulatory body continuously updates its guidelines to ensure the quality and safety of these products.

While these regulatory frameworks aim to ensure product safety and efficacy, they can also pose challenges for NGS manufacturers and service providers. Adhering to dynamic and stringent regulations can be time-consuming and costly, potentially impeding the rate of innovation and market expansion. Conversely, clear and supportive regulatory policies can expedite product approval processes, boost end-user confidence, and drive market growth. Therefore, understanding and navigating the regulatory landscape is crucial for stakeholders in the NGS market.

Competitive Analysis

Top participants profiled in the market:

10X Genomics
BGI
Agilent Technologies, Inc.
Bio-Rad Laboratories
GenapSys Inc.
F. Hoffmann-La Roche
Illumina, Inc.
Oxford Nanopore Technologies
NanoString Technologies, Inc.
Pacific Biosciences of California, Inc.
Qiagen
PerkinElmer Inc.
Thermo Fisher Scientific.

Recent developments and news

2020:

June: Illumina, Inc. acquires BlueBee, a cloud-based software company offering genomics analysis solutions.
May: Roche acquires the early-stage sequencing technology firm Stratos Genomics, aiming to advance Roche’s nanopore sequencer development.

2021:

May: Illumina, Inc. collaborates with Next Generation Genomic Co., Ltd. to launch the VeriSeq NIPT Solution v2 in Thailand, a CE-IVD NGS-based noninvasive prenatal testing (NIPT).
February:
- QIAGEN and INOVIO Pharmaceuticals extend their partnership to develop liquid biopsy-based companion diagnostic products to enhance INOVIO’s therapies using NGS technology.
- Thermo Fisher Scientific forms a partnership with SPT Labtech Ltd., co-marketing Thermo Fisher’s NGS library preparation products.
June: QIAGEN N.V. partners with Verogen Inc. to enhance the automation of NGS library prep kits, expanding Biomek NGenuiS liquid handler applications. They aim to commercialize forensic workflows for NGS, merging QIAGEN’s QIAseq products with Verogen’s offerings.
September: Beckman Coulter, Inc. collaborates with Invitae Corporation to develop new applications for the Biomek NGeniuS System.
November: Beckman Coulter, Inc. teams up with Integrated DNA Technologies, Inc. to innovate the Biomek NGeniuS System, making NGS solutions more accessible.

2022:

Early: Illumina announces the NovaSeq Xp sequencing system, aiming to make whole-genome sequencing more affordable and revolutionize the industry.
February: Beckman Coulter, Inc. collaborates with Illumina, Inc. to develop new applications for the Biomek NGeniuS System.
Mid: Thermo Fisher Scientific introduces the Ion Torrent Genexus Dx, an NGS system for clinical diagnostic labs, offering results within a day.
November: Illumina partners with Twist Bioscience to introduce the Exome 2.0 Plus panel for disease research, packaging it with DNA library preparation reagents.

2023:

January:
- BGI Genomics establishes a genomic research center in India, solidifying its presence in the Asian market.
- QIAGEN partners with Helix OpCo, LLC, enhancing the adoption of NGS companion diagnostics in hereditary diseases.
March: QIAGEN teams up with Sophia Genetics to leverage NGS strengths, providing clients with superior QIAGEN NGS preparation kits.
Late: Oxford Nanopore Technologies unveils an upgraded MinION device with doubled sequencing capacity, enhancing long-read sequencing accessibility.

Segmentation Analysis

Geographically, the global market for next-generation sequencing is examined across various regional markets, including:

North America:
- United States
- Canada
Europe:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Asia Pacific:
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America:
- Brazil
- Mexico
- Rest of Latin America
Middle East and Africa:
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

This study presents the market size and forecast for these regional and country-level markets for the period of 2020–2030. The report also includes market growth rates for the forecast period, considering 2021 as the base year.

In addition to quantitative information, this study provides qualitative information sets and assessment tools to facilitate a comprehensive analysis of the overall market scenario and future prospects. Readers can gain a better understanding of the global Next Generation Sequencing market by exploring insights such as market trends, drivers, challenges, and opportunities.

Moreover, the report offers tools like key player market positioning and an attractive investment proposition, providing readers with valuable insights into the competitive landscape of the global Next-Generation Sequencing market. The report concludes with a section featuring company profiles that highlight key information about the major players operating in the market. Furthermore, the report provides an in-depth analysis of the competitive environment and historical market size data for the years 2019 and 2020.

This research study provides a comprehensive view of the global Next Generation Sequencing market, offering market size estimates for the period from 2024 to 2030 while considering the factors mentioned above.

Based on the type of application, the next-generation sequencing market is segmented into:

Oncology

Genetic Screening

Infectious Diseases

Drug and biomarker discovery

Agriculture and animal research

Idiopathic Diseases

Others

Next-generation sequencing (NGS) technologies offer significant advantages in terms of cost-effectiveness, unparalleled sequencing speed, high resolution, and genomic analysis accuracy. Various applications of next-generation sequencing are broadly categorized into oncology, genetic screening, infectious diseases, drug and biomarker discovery, agriculture and animal research, idiopathic diseases, and others. Technological advancements in the next-generation sequencing market are expected to enable researchers to generate phase-resolved HLA sequences in single read cycles and provide insights into the less accessible regions of HLA genes.

Furthermore, the development of prenatal genome sequencing for the analysis of genetic anomalies and diseases is also expected to witness increased demand, thereby driving the genetic screening market. The growing incidence of cancer and infectious diseases, along with the increasing use of next-generation sequencing in developing biopharmaceuticals and drugs for their treatment, is further expected to drive the demand for next-generation sequencing. These factors are expected to have a significant impact on the sustained high growth of the next-generation sequencing market throughout the forecast period.

Based on the type of technology, the next-generation sequencing market is segmented into:

Whole Genome Sequencing

Targeted Resequencing

RNA Sequencing

Whole-exome sequencing

Sequencing from Scratch

Technologically, the approaches for any next-generation sequencing procedure can be categorized into whole genome sequencing, targeted resequencing, RNA sequencing, whole exome sequencing, and de novo sequencing. The primary difference between these approaches is the number of base pairs sequenced in a given sequencing cycle. With advancements in technology and the development of high-throughput sequencing platforms such as HiSeq and MiSeq, it has become increasingly efficient to sequence a larger number of base pairs in single-cycle reads.

Targeted resequencing focuses on sequencing genes that are less than 1 million base pairs in length, whereas technological advancements in NGS sequencing technology have enabled efficient and rapid sequencing capacity to read the entire human genome, which consists of 3 billion base pairs. Targeted resequencing currently holds the largest share in the global next-generation sequencing market due to its accuracy and increasing preference in research and development. De novo sequencing is anticipated to grow at the fastest rate during the forecast period due to its faster and more accurate characterization of any species compared to traditional methods.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

For the purpose of this study, the global next-generation sequencing market is classified into the following regions:

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

The global next-generation sequencing market is segmented into six regional markets: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In the base year 2020, North America emerged as the largest revenue-generating market for next-generation sequencing, with the U.S. holding the largest market share. The market is primarily driven by technological advancements in the field of life sciences, the availability of commercial solutions for next-generation sequencing data analysis, and the presence of key players in the region.

Furthermore, government institutions’ extended support for genomic research in drug discovery and genetic screening is also contributing to the growth of the next-generation sequencing market in North America and Europe. Asia-Pacific is expected to witness the highest growth rate during the forecast period, driven by increasing medical awareness among the regional population, rising investments in healthcare development, and growing oncology and infectious disease research in the region.

Chapter No. 1 : Introduction 30

1.1. Report Description 30

1.1.1. Purpose of the Report 30

1.1.2. USP & Key Offerings 30

1.2. Key Benefits for Stakeholders 30

1.3. Target Audience 31

1.4. Report Scope 32

Chapter No. 2 : Executive Summary 34

2.1. Next Generation Sequencing Market Snapshot 34

2.2. Global Next Generation Sequencing Market, 2017 – 2022 (USD Million) 35

Chapter No. 3 : Impact Analysis of COVID 19 & Russia-Ukraine War on Next Generation Sequencing Market 36

3.1. Impact Assessment of COVID-19 Pandemic, By Region 36

3.1.1. Supply chain disruptions 36

3.1.2. Demand fluctuations 36

3.1.3. Shift in product mix 36

3.1.4. Reduced industrial activity 36

3.1.5. Temporary disruptions and delays 36

3.1.6. Shift in focus towards essential services 36

3.2. Russia-Ukraine War Impacts 37

3.2.1. Uncertainty and economic instability 37

3.2.2. Supply chain disruptions 37

3.2.3. Regional market shifts 37

3.2.4. Shift in government priorities 37

Chapter No. 4 : Next Generation Sequencing Market – Industry Analysis 38

4.1. Introduction 38

4.2. Market Drivers 39

4.2.1. Driving Factor 1 Analysis 39

4.2.2. Driving Factor 2 Analysis 40

4.3. Market Restraints 41

4.3.1. Restraining Factor Analysis 41

4.4. Market Opportunities 42

4.4.1. Market Opportunity Analysis 42

4.5. Porter’s Five Forces Analysis 43

4.6. Value Chain Analysis 44

4.7. Buying Criteria 45

Chapter No. 5 : Analysis Competitive Landscape 46

5.1. Company Market Share Analysis – 2022 46

5.1.1. Global Next Generation Sequencing Market: Company Market Share, by Revenue2022 46

5.1.2. Global Next Generation Sequencing Market: Top 6 Company Market Share, by Revenue2022 46

5.1.3. Global Next Generation Sequencing Market: Top 3 Company Market Share, by Revenue2022 47

5.1. Global Next Generation Sequencing Market Company Revenue Market Share, 2022 48

5.2. Company Assessment Metrics, 2022 49

5.2.1. Stars 49

5.2.2. Emerging Leaders 49

5.2.3. Pervasive Players 49

5.2.4. Participants 49

5.3. Start-ups /SMEs Assessment Metrics, 2022 49

5.3.1. Progressive Companies 49

5.3.2. Responsive Companies 49

5.3.3. Dynamic Companies 49

5.3.4. Starting Blocks 49

5.4. Strategic Developments 50

5.4.1. Acquisitions & Mergers 50

5.4.2. New Product Launch 50

5.4.3. Regional Expansion 50

5.5. Key Players Product Matrix 51

Chapter No. 6 : PESTEL & Adjacent Market Analysis 52

6.1. PESTEL 52

6.1.1. Political Factors 52

6.1.2. Economic Factors 52

6.1.3. Social Factors 52

6.1.4. Technological Factors 52

6.1.5. Environmental Factors 52

6.1.6. Legal Factors 52

6.2. Adjacent Market Analysis 52

Chapter No. 7 : Next Generation Sequencing Market – By Type Segment Analysis 53

7.1. Next Generation Sequencing Market Overview, by Type Segment 53

7.1.1. Next Generation Sequencing Market Revenue Share, By Type, 2022 & 2030 54

7.1.2. Next Generation Sequencing Market Attractiveness Analysis, By Type 55

7.1.3. Incremental Revenue Growth Opportunity, by Type, 2023 – 2030 55

7.1.4. Next Generation Sequencing Market Revenue, By Type, 2017, 2022, 2026 & 2030 56

7.2. Sequencing Services 57

7.2.1. Global Sequencing Services Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 58

7.2.2. Global Sequencing Services Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 58

7.3. Product By Technology 59

7.3.1. Global Product By Technology Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 60

7.3.2. Global Product By Technology Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 60

Chapter No. 8 : Next Generation Sequencing Market – By Application Segment Analysis 61

8.1. Next Generation Sequencing Market Overview, by Application Segment 61

8.1.1. Next Generation Sequencing Market Revenue Share, By Application, 2022 & 2030 62

8.1.2. Next Generation Sequencing Market Attractiveness Analysis, By Application 63

8.1.3. Incremental Revenue Growth Opportunity, by Application, 2023 – 2030 63

8.1.4. Next Generation Sequencing Market Revenue, By Application, 2017, 2022, 2026 & 2030 64

8.2. Bioinformatics 65

8.2.1. Global Bioinformatics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 66

8.2.2. Global Bioinformatics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 66

8.3. Diagnostics 67

8.3.1. Global Diagnostics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 68

8.3.2. Global Diagnostics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 68

8.4. Agriculture and Animal Research 69

8.4.1. Global Agriculture and Animal Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 70

8.4.2. Global Agriculture and Animal Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 70

8.5. Drug Discovery 71

8.5.1. Global Drug Discovery Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 72

8.5.2. Global Drug Discovery Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 72

8.6. Genetic Research 73

8.6.1. Global Genetic Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 74

8.6.2. Global Genetic Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 74

8.7. Others (Clinical Bacteriology, Oncology,Etc.) 74

Chapter No. 9 : Next Generation Sequencing Market – By End-user Segment Analysis 75

9.1. Next Generation Sequencing Market Overview, by End-user Segment 75

9.1.1. Next Generation Sequencing Market Revenue Share, By End-user, 2022 & 2030 76

9.1.2. Next Generation Sequencing Market Attractiveness Analysis, By End-user 77

9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2023 – 2030 77

9.1.4. Next Generation Sequencing Market Revenue, By End-user, 2017, 2022, 2026 & 2030 78

9.2. Research Institutes 79

9.2.1. Global Research Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 80

9.2.2. Global Research Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 80

9.3. Pharmaceuticals 81

9.3.1. Global Pharmaceuticals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 82

9.3.2. Global Pharmaceuticals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 82

9.4. Biotechnology Companies 83

9.4.1. Global Biotechnology Companies Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 84

9.4.2. Global Biotechnology Companies Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 84

9.5. Hospitals 85

9.5.1. Global Hospitals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 86

9.5.2. Global Hospitals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 86

9.6. Academic Institutes 87

9.6.1. Global Academic Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 88

9.6.2. Global Academic Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 88

Chapter No. 10 : Next Generation Sequencing Market – By Technology Segment Analysis 89

10.1. Next Generation Sequencing Market Overview, by Technology Segment 89

10.1.1. Next Generation Sequencing Market Revenue Share, By Technology, 2022 & 2030 90

10.1.2. Next Generation Sequencing Market Attractiveness Analysis, By Technology 91

10.1.3. Incremental Revenue Growth Opportunity, by Technology, 2023 – 2030 91

10.1.4. Next Generation Sequencing Market Revenue, By Technology, 2017, 2022, 2026 & 2030 92

10.2. Sequencing by Synthesis 93

10.2.1. Global Sequencing by Synthesis Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 94

10.2.2. Global Sequencing by Synthesis Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 94

10.3. Sequencing by Ligation 95

10.3.1. Global Sequencing by Ligation Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 96

10.3.2. Global Sequencing by Ligation Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 96

10.4. Ion Semiconductor Sequencing 97

10.4.1. Global Ion Semiconductor Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 98

10.4.2. Global Ion Semiconductor Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 98

10.5. Nanopore Sequencing 99

10.5.1. Global Nanopore Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 100

10.5.2. Global Nanopore Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 100

10.6. Others 101

10.6.1. Global Others Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 102

10.6.2. Global Others Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 102

Chapter No. 11 : Next Generation Sequencing Market – By Diagnostics Segment Analysis 103

11.1. Next Generation Sequencing Market Overview, by Diagnostics Segment 103

11.1.1. Next Generation Sequencing Market Revenue Share, By Diagnostics, 2022 & 2030 104

11.1.2. Next Generation Sequencing Market Attractiveness Analysis, By Diagnostics 105

11.1.3. Incremental Revenue Growth Opportunity, by Diagnostics, 2023 – 2030 105

11.1.4. Next Generation Sequencing Market Revenue, By Diagnostics, 2017, 2022, 2026 & 2030 106

11.2. Cancer 107

11.2.1. Global Cancer Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 108

11.2.2. Global Cancer Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 108

11.3. Neonatal Screening 109

11.3.1. Global Neonatal Screening Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 110

11.3.2. Global Neonatal Screening Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 110

11.4. Infectious Disease 111

11.4.1. Global Infectious Disease Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 112

11.4.2. Global Infectious Disease Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 112

11.5. Reproductive Health 113

11.5.1. Global Reproductive Health Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 114

11.5.2. Global Reproductive Health Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 114

11.6. Genetic Testing 115

11.6.1. Global Genetic Testing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 116

11.6.2. Global Genetic Testing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 116

Chapter No. 12 : Next Generation Sequencing Market – Regional Analysis 117

12.1. Next Generation Sequencing Market Overview, by Regional Segments 117

12.2. Region 118

12.2.1. Global Next Generation Sequencing Market Revenue Share, By Region, 2022 & 2030 118

12.2.2. Next Generation Sequencing Market Attractiveness Analysis, By Region 119

12.2.3. Incremental Revenue Growth Opportunity, by Region, 2023 – 2030 119

12.2.4. Next Generation Sequencing Market Revenue, By Region, 2017, 2022, 2026 & 2030 120

12.2.5. Global Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 121

12.2.6. Global Next Generation Sequencing Market Revenue, By Region, 2023 – 2030 (USD Million) 121

12.3. Type 122

12.3.1. Global Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 122

12.3.2. Global Next Generation Sequencing Market Revenue, By Type, 2023 – 2030 (USD Million) 122

12.4. Application 123

12.4.1. Global Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 123

12.4.2. Global Next Generation Sequencing Market Revenue, By Application, 2023 – 2030 (USD Million) 123

12.5. End-user 124

12.5.1. Global Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 124

12.5.2. Global Next Generation Sequencing Market Revenue, By End-user, 2023 – 2030 (USD Million) 124

12.6. Technology 125

12.6.1. Global Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 125

12.6.2. Global Next Generation Sequencing Market Revenue, By Technology, 2023 – 2030 (USD Million) 125

12.7. Diagnostics 126

12.7.1. Global Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 126

12.7.2. Global Next Generation Sequencing Market Revenue, By Diagnostics, 2023 – 2030 (USD Million) 126

Chapter No. 13 : Next Generation Sequencing Market – North America 127

13.1. North America 127

13.1. Key Highlights 127

13.1.1. North America Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 128

13.1.2. North America Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 129

13.1.3. North America Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 130

13.1.4. North America Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 131

13.1.5. North America Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 132

13.1.6. North America Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 133

13.1.7. U.S. 134

13.1.8. Canada 134

13.1.9. Mexico 134

Chapter No. 14 : Next Generation Sequencing Market – Europe 135

14.1. Europe 135

14.2. Key Highlights 135

14.2.1. Europe Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 136

14.2.2. Europe Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 138

14.2.3. Europe Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 139

14.2.4. Europe Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 140

14.2.5. Europe Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 141

14.2.6. Europe Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 142

14.2.7. UK 143

14.2.8. France 143

14.2.9. Germany 143

14.2.10. Italy 143

14.2.11. Spain 143

14.2.12. Russia 143

14.2.13. BENELUX 143

14.2.14. Sweden 143

14.2.15. Denmark 143

14.2.16. Poland 143

14.2.17. Austria 143

14.2.18. Rest of Europe 143

Chapter No. 15 : Next Generation Sequencing Market – Asia Pacific 144

15.1. Asia Pacific 144

15.2. Key Highlights 144

15.2.1. Asia Pacific Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 145

15.2.2. Asia Pacific Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 147

15.2.3. Asia Pacific Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 148

15.2.4. Asia Pacific Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 149

15.2.5. Asia Pacific Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 150

15.2.6. Asia Pacific Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 151

15.2.7. China 152

15.2.8. Japan 152

15.2.9. South Korea 152

15.2.10. India 152

15.2.11. Thailand 152

15.2.12. Indonesia 152

15.2.13. Vietnam 152

15.2.14. Malaysia 152

15.2.15. Philippines 152

15.2.16. Taiwan 152

15.2.17. Rest of Asia Pacific 152

Chapter No. 16 : Next Generation Sequencing Market – Latin America 153

16.1. Latin America 153

16.2. Key Highlights 153

16.2.1. Latin America Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 154

16.2.2. Latin America Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 155

16.2.3. Latin America Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 156

16.2.4. Latin America Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 157

16.2.5. Latin America Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 158

16.2.6. Latin America Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 159

16.2.7. Brazil 160

16.2.8. Argentina 160

16.2.9. Colombia 160

16.2.10. Chile 160

16.2.11. Peru 160

16.2.12. Rest of Latin America 160

Chapter No. 17 : Next Generation Sequencing Market – Middle East 161

17.1. The Middle-East 161

17.2. Key Highlights 161

17.2.1. Middle East Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 162

17.2.2. Middle East Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 163

17.2.3. Middle East Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 164

17.2.4. Middle East Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 165

17.2.5. Middle East Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 166

17.2.6. Middle East Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 167

17.2.7. GCC Countries 168

17.2.8. Israel 168

17.2.9. Turkey 168

17.2.10. Iran 168

17.2.11. Rest of Middle East & Africa 168

Chapter No. 18 : Next Generation Sequencing Market – Africa 169

18.1. Africa 169

18.2. Key Highlights 169

18.2.1. Africa Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 170

18.2.2. Africa Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 171

18.2.3. Africa Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 172

18.2.4. Africa Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 173

18.2.5. Africa Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 174

18.2.6. Africa Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 175

18.2.7. South Africa 176

18.2.8. Egypt 176

18.2.9. Nigeria 176

18.2.10. Algeria 176

18.2.11. Morocco 176

18.2.12. Rest of Africa 176

Chapter No. 19 : Company Profiles 177

19.1. Illumina 177

19.1.1. Company Overview 177

19.1.2. Product Portfolio 177

19.1.3. Swot Analysis 177

19.1.4. Business Strategy 178

19.1.5. Financial Overview 178

19.2. F. Hoffman-La Roche Ltd. 179

19.3. QIAGEN 179

19.4. Thermo Fisher Scientific, Inc. 179

19.5. Bio-Rad Laboratories, Inc. 179

19.6. Oxford Nanopore Technologies 179

19.7. PierianDx 179

19.8. Genomatix GmbH 179

19.9. DNASTAR, Inc. 179

19.10. Perkin Elmer, Inc. 179

19.11. Eurofins GATC Biotech GmbH 179

19.12. BGI 179

Chapter No. 20 : Research Methodology 180

20.1. Research Methodology 180

20.2. Phase I – Secondary Research 181

20.3. Phase II – Data Modeling 181

20.3.1. Company Share Analysis Model 182

20.3.2. Revenue Based Modeling 182

20.4. Phase III – Primary Research 183

20.5. Research Limitations 184

20.5.1. Assumptions 184

List of Figures

FIG NO. 1. Global Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 35

FIG NO. 2. Porter’s Five Forces Analysis for Global Next Generation Sequencing Market 43

FIG NO. 3. Value Chain Analysis for Global Next Generation Sequencing Market 44

FIG NO. 4. Company Share Analysis, 2022 46

FIG NO. 5. Company Share Analysis, 2022 46

FIG NO. 6. Company Share Analysis, 2022 47

FIG NO. 7. Next Generation Sequencing Market – Company Revenue Market Share, 2022 48

FIG NO. 8. Next Generation Sequencing Market Revenue Share, By Type, 2022 & 2030 54

FIG NO. 9. Market Attractiveness Analysis, By Type 55

FIG NO. 10. Incremental Revenue Growth Opportunity by Type 55

FIG NO. 11. Next Generation Sequencing Market Revenue, By Type, 2017, 2022, 2026 & 2030 56

FIG NO. 12. Global Next Generation Sequencing Market for Sequencing Services, Revenue (USD Million) 2017 – 2030 57

FIG NO. 13. Global Next Generation Sequencing Market for Product By Technology, Revenue (USD Million) 2017 – 2030 59

FIG NO. 14. Next Generation Sequencing Market Revenue Share, By Application, 2022 & 2030 62

FIG NO. 15. Market Attractiveness Analysis, By Application 63

FIG NO. 16. Incremental Revenue Growth Opportunity by Application 63

FIG NO. 17. Next Generation Sequencing Market Revenue, By Application, 2017, 2022, 2026 & 2030 64

FIG NO. 18. Global Next Generation Sequencing Market for Bioinformatics, Revenue (USD Million) 2017 – 2030 65

FIG NO. 19. Global Next Generation Sequencing Market for Diagnostics, Revenue (USD Million) 2017 – 2030 67

FIG NO. 20. Global Next Generation Sequencing Market for Agriculture and Animal Research, Revenue (USD Million) 2017 – 2030 69

FIG NO. 21. Global Next Generation Sequencing Market for Drug Discovery, Revenue (USD Million) 2017 – 2030 71

FIG NO. 22. Global Next Generation Sequencing Market for Genetic Research, Revenue (USD Million) 2017 – 2030 73

FIG NO. 23. Next Generation Sequencing Market Revenue Share, By End-user, 2022 & 2030 76

FIG NO. 24. Market Attractiveness Analysis, By End-user 77

FIG NO. 25. Incremental Revenue Growth Opportunity by End-user 77

FIG NO. 26. Next Generation Sequencing Market Revenue, By End-user, 2017, 2022, 2026 & 2030 78

FIG NO. 27. Global Next Generation Sequencing Market for Research Institutes, Revenue (USD Million) 2017 – 2030 79

FIG NO. 28. Global Next Generation Sequencing Market for Pharmaceuticals, Revenue (USD Million) 2017 – 2030 81

FIG NO. 29. Global Next Generation Sequencing Market for Biotechnology Companies, Revenue (USD Million) 2017 – 2030 83

FIG NO. 30. Global Next Generation Sequencing Market for Hospitals, Revenue (USD Million) 2017 – 2030 85

FIG NO. 31. Global Next Generation Sequencing Market for Academic Institutes, Revenue (USD Million) 2017 – 2030 87

FIG NO. 32. Next Generation Sequencing Market Revenue Share, By Technology, 2022 & 2030 90

FIG NO. 33. Market Attractiveness Analysis, By Technology 91

FIG NO. 34. Incremental Revenue Growth Opportunity by Technology 91

FIG NO. 35. Next Generation Sequencing Market Revenue, By Technology, 2017, 2022, 2026 & 2030 92

FIG NO. 36. Global Next Generation Sequencing Market for Sequencing by Synthesis, Revenue (USD Million) 2017 – 2030 93

FIG NO. 37. Global Next Generation Sequencing Market for Sequencing by Ligation, Revenue (USD Million) 2017 – 2030 95

FIG NO. 38. Global Next Generation Sequencing Market for Ion Semiconductor Sequencing, Revenue (USD Million) 2017 – 2030 97

FIG NO. 39. Global Next Generation Sequencing Market for Nanopore Sequencing, Revenue (USD Million) 2017 – 2030 99

FIG NO. 40. Global Next Generation Sequencing Market for Others, Revenue (USD Million) 2017 – 2030 101

FIG NO. 41. Next Generation Sequencing Market Revenue Share, By Diagnostics, 2022 & 2030 104

FIG NO. 42. Market Attractiveness Analysis, By Diagnostics 105

FIG NO. 43. Incremental Revenue Growth Opportunity by Diagnostics 105

FIG NO. 44. Next Generation Sequencing Market Revenue, By Diagnostics, 2017, 2022, 2026 & 2030 106

FIG NO. 45. Global Next Generation Sequencing Market for Cancer, Revenue (USD Million) 2017 – 2030 107

FIG NO. 46. Global Next Generation Sequencing Market for Neonatal Screening, Revenue (USD Million) 2017 – 2030 109

FIG NO. 47. Global Next Generation Sequencing Market for Infectious Disease, Revenue (USD Million) 2017 – 2030 111

FIG NO. 48. Global Next Generation Sequencing Market for Reproductive Health, Revenue (USD Million) 2017 – 2030 113

FIG NO. 49. Global Next Generation Sequencing Market for Genetic Testing, Revenue (USD Million) 2017 – 2030 115

FIG NO. 50. Global Next Generation Sequencing Market Revenue Share, By Region, 2022 & 2030 118

FIG NO. 51. Market Attractiveness Analysis, By Region 119

FIG NO. 52. Incremental Revenue Growth Opportunity by Region 119

FIG NO. 53. Next Generation Sequencing Market Revenue, By Region, 2017, 2022, 2026 & 2030 120

FIG NO. 54. North America Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 127

FIG NO. 55. Europe Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 135

FIG NO. 56. Asia Pacific Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 144

FIG NO. 57. Latin America Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 153

FIG NO. 58. The Middle-East Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 161

FIG NO. 59. Africa Next Generation Sequencing Market Revenue, 2017 – 2022 (USD Million) 169

FIG NO. 60. Research Methodology – Detailed View 180

FIG NO. 61. Research Methodology 181

List of Tables

TABLE NO. 1. : Global Next Generation Sequencing Market: Snapshot 33

TABLE NO. 2. : Drivers for the Next Generation Sequencing Market: Impact Analysis 38

TABLE NO. 3. : Restraints for the Next Generation Sequencing Market: Impact Analysis 40

TABLE NO. 4. : Global Sequencing Services Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 57

TABLE NO. 5. : Global Sequencing Services Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 57

TABLE NO. 6. : Global Product By Technology Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 59

TABLE NO. 7. : Global Product By Technology Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 59

TABLE NO. 8. : Global Bioinformatics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 65

TABLE NO. 9. : Global Bioinformatics Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 65

TABLE NO. 10. : Global Diagnostics Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 67

TABLE NO. 11. : Global Diagnostics Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 67

TABLE NO. 12. : Global Agriculture and Animal Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 69

TABLE NO. 13. : Global Agriculture and Animal Research Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 69

TABLE NO. 14. : Global Drug Discovery Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 71

TABLE NO. 15. : Global Drug Discovery Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 71

TABLE NO. 16. : Global Genetic Research Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 73

TABLE NO. 17. : Global Genetic Research Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 73

TABLE NO. 18. : Global Research Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 79

TABLE NO. 19. : Global Research Institutes Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 79

TABLE NO. 20. : Global Pharmaceuticals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 81

TABLE NO. 21. : Global Pharmaceuticals Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 81

TABLE NO. 22. : Global Biotechnology Companies Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 83

TABLE NO. 23. : Global Biotechnology Companies Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 83

TABLE NO. 24. : Global Hospitals Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 85

TABLE NO. 25. : Global Hospitals Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 85

TABLE NO. 26. : Global Academic Institutes Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 87

TABLE NO. 27. : Global Academic Institutes Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 87

TABLE NO. 28. : Global Sequencing by Synthesis Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 93

TABLE NO. 29. : Global Sequencing by Synthesis Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 93

TABLE NO. 30. : Global Sequencing by Ligation Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 95

TABLE NO. 31. : Global Sequencing by Ligation Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 95

TABLE NO. 32. : Global Ion Semiconductor Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 97

TABLE NO. 33. : Global Ion Semiconductor Sequencing Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 97

TABLE NO. 34. : Global Nanopore Sequencing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 99

TABLE NO. 35. : Global Nanopore Sequencing Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 99

TABLE NO. 36. : Global Others Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 101

TABLE NO. 37. : Global Others Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 101

TABLE NO. 38. : Global Cancer Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 107

TABLE NO. 39. : Global Cancer Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 107

TABLE NO. 40. : Global Neonatal Screening Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 109

TABLE NO. 41. : Global Neonatal Screening Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 109

TABLE NO. 42. : Global Infectious Disease Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 111

TABLE NO. 43. : Global Infectious Disease Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 111

TABLE NO. 44. : Global Reproductive Health Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 113

TABLE NO. 45. : Global Reproductive Health Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 113

TABLE NO. 46. : Global Genetic Testing Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 115

TABLE NO. 47. : Global Genetic Testing Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 115

TABLE NO. 48. : Global Next Generation Sequencing Market Revenue, By Region, 2017 – 2022 (USD Million) 120

TABLE NO. 49. : Global Next Generation Sequencing Market Revenue, By Region, 2023– 2030 (USD Million) 120

TABLE NO. 50. : Global Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 121

TABLE NO. 51. : Global Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 121

TABLE NO. 52. : Global Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 122

TABLE NO. 53. : Global Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 122

TABLE NO. 54. : Global Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 123

TABLE NO. 55. : Global Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 123

TABLE NO. 56. : Global Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 124

TABLE NO. 57. : Global Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 124

TABLE NO. 58. : Global Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 125

TABLE NO. 59. : Global Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 125

TABLE NO. 60. : North America Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 127

TABLE NO. 61. : North America Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 127

TABLE NO. 62. : North America Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 128

TABLE NO. 63. : North America Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 128

TABLE NO. 64. : North America Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 129

TABLE NO. 65. : North America Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 129

TABLE NO. 66. : North America Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 130

TABLE NO. 67. : North America Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 130

TABLE NO. 68. : North America Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 131

TABLE NO. 69. : North America Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 131

TABLE NO. 70. : North America Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 132

TABLE NO. 71. : North America Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 132

TABLE NO. 72. : Europe Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 135

TABLE NO. 73. : Europe Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 135

TABLE NO. 74. : Europe Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 137

TABLE NO. 75. : Europe Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 137

TABLE NO. 76. : Europe Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 138

TABLE NO. 77. : Europe Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 138

TABLE NO. 78. : Europe Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 139

TABLE NO. 79. : Europe Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 139

TABLE NO. 80. : Europe Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 140

TABLE NO. 81. : Europe Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 140

TABLE NO. 82. : Europe Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 141

TABLE NO. 83. : Europe Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 141

TABLE NO. 84. : Asia Pacific Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 144

TABLE NO. 85. : Asia Pacific Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 144

TABLE NO. 86. : Asia Pacific Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 146

TABLE NO. 87. : Asia Pacific Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 146

TABLE NO. 88. : Asia Pacific Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 147

TABLE NO. 89. : Asia Pacific Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 147

TABLE NO. 90. : Asia Pacific Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 148

TABLE NO. 91. : Asia Pacific Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 148

TABLE NO. 92. : Asia Pacific Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 149

TABLE NO. 93. : Asia Pacific Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 149

TABLE NO. 94. : Asia Pacific Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 150

TABLE NO. 95. : Asia Pacific Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 150

TABLE NO. 96. : Latin America Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 153

TABLE NO. 97. : Latin America Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 153

TABLE NO. 98. : Latin America Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 154

TABLE NO. 99. : Latin America Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 154

TABLE NO. 100. : Latin America Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 155

TABLE NO. 101. : Latin America Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 155

TABLE NO. 102. : Latin America Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 156

TABLE NO. 103. : Latin America Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 156

TABLE NO. 104. : Latin America Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 157

TABLE NO. 105. : Latin America Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 157

TABLE NO. 106. : Latin America Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 158

TABLE NO. 107. : Latin America Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 158

TABLE NO. 108. : Middle East Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 161

TABLE NO. 109. : Middle East Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 161

TABLE NO. 110. : Middle East Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 162

TABLE NO. 111. : Middle East Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 162

TABLE NO. 112. : Middle East Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 163

TABLE NO. 113. : Middle East Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 163

TABLE NO. 114. : Middle East Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 164

TABLE NO. 115. : Middle East Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 164

TABLE NO. 116. : Middle East Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 165

TABLE NO. 117. : Middle East Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 165

TABLE NO. 118. : Middle East Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 166

TABLE NO. 119. : Middle East Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 166

TABLE NO. 120. : Africa Next Generation Sequencing Market Revenue, By Country, 2017 – 2022 (USD Million) 169

TABLE NO. 121. : Africa Next Generation Sequencing Market Revenue, By Country, 2023– 2030 (USD Million) 169

TABLE NO. 122. : Africa Next Generation Sequencing Market Revenue, By Type, 2017 – 2022 (USD Million) 170

TABLE NO. 123. : Africa Next Generation Sequencing Market Revenue, By Type, 2023– 2030 (USD Million) 170

TABLE NO. 124. : Africa Next Generation Sequencing Market Revenue, By Application, 2017 – 2022 (USD Million) 171

TABLE NO. 125. : Africa Next Generation Sequencing Market Revenue, By Application, 2023– 2030 (USD Million) 171

TABLE NO. 126. : Africa Next Generation Sequencing Market Revenue, By End-user, 2017 – 2022 (USD Million) 172

TABLE NO. 127. : Africa Next Generation Sequencing Market Revenue, By End-user, 2023– 2030 (USD Million) 172

TABLE NO. 128. : Africa Next Generation Sequencing Market Revenue, By Technology, 2017 – 2022 (USD Million) 173

TABLE NO. 129. : Africa Next Generation Sequencing Market Revenue, By Technology, 2023– 2030 (USD Million) 173

TABLE NO. 130. : Africa Next Generation Sequencing Market Revenue, By Diagnostics, 2017 – 2022 (USD Million) 174

TABLE NO. 131. : Africa Next Generation Sequencing Market Revenue, By Diagnostics, 2023– 2030 (USD Million) 174

Frequently Asked Questions:

What is the current valuation of the NGS market and its projected growth by 2030?

The NGS market was valued at USD 5,809.8 million in 2022. By 2030, it’s expected to reach a valuation of USD 21,485.69 million, growing at a CAGR of 20.54% from 2023 to 2030.

What drives the growth of the NGS market?

Growth drivers include the emergence of genomic medicine, technological advancements in NGS platforms, an increase in R&D activities in genomics, and a growing awareness of genetic disorders. The trend towards personalized and precise medical approaches, leading to the need for comprehensive genomic profiling, also plays a significant role.

Are there challenges facing the NGS market?

Yes, challenges include the high costs of NGS technologies, a shortage of skilled professionals for data interpretation, data storage and management issues, and concerns related to data security and privacy. Ethical implications around genome sequencing, such as issues of consent and potential misuse of genetic information, also present challenges.

How do regulatory bodies impact the NGS market?

Regulatory bodies like the FDA, EMA, and NMPA establish guidelines for NGS-based product development, clinical testing, and diagnostic applications. While these regulations ensure product safety and efficacy, they can also pose challenges for NGS manufacturers due to the stringent nature of the regulations. Clear and supportive regulatory policies, on the other hand, can expedite product approval processes and drive market growth.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –